Study on the expression and clinical significances of Lewis y antigen and integrin αv, β3 in epithelial ovarian tumors

International Journal of Molecular Sciences

Volumn 12, Issue 6, 2011, Pages 3409-3421

  Wang, Yifei ^a,b   Liu, Juanjuan ^a   Lin, Bei ^a   Wang, Changzhi ^b   Li, Quanrong ^a   Liu, Shuice ^a   Yan, Limei ^a   Zhang, Shulan ^a   Iwamori, Masao ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Epithelial ovarian tumor; Immunofluorescence double labeling method; Immunohistochemistry; Integrin av 3; Lewis y antigen

Indexed keywords

BLOOD GROUP ANTIGEN; LEWIS Y ANTIGEN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; BLOOD GROUP LEWIS SYSTEM; FLUORESCENT DYE;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; EPITHELIAL OVARIAN TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PROTEIN EXPRESSION; ABDOMINAL TUMOR; ADULT; AGED; BLOOD GROUP LEWIS SYSTEM; CHEMISTRY; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY; SECONDARY;

ABDOMINAL NEOPLASMS; ADULT; AGED; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; LEWIS BLOOD-GROUP SYSTEM; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 79959754818     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12063409     Document Type: Article

References (23)

1. Senitiroh, H. The glycosynapse. Proc. Natl. Acad. Sci. USA 2002, 99, 225-232.
2. Coon, J.S.; Weinstein, R.S. Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum. Pathol. 1986, 17, 1089-1106.
3. Dettke, M.; Pálfi, G.; Loibner, H. Activation-dependent expression of the blood group-related Lewis Y antigen on periperal blood granulocytes. J. Leukoc. Biol. 2000, 68, 511-514.
4. Hellström, I.; Garrigues, H.J.; Garrigues, U.; Hellström, K.E. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res. 1990, 50, 2183-2190.
5. Leroy-Dudal, J.; Heyman, L.; Gauduchon, P.; Carreiras, F. Adhesion of human ovarian adenocarcinoma IGROV1 cells to endothelial cells is partly mediated by the alphav integrins-vitronectin adhesive system and induces an alteration of endothelial integrity. Cell Biol. Int. 2005, 29, 482-488.
6. Yan, L.M.; Lin, B.; Zhu, L.C.; Hao, Y.Y.; Qi, Y.; Wang, C.Z.; Gao, S.; Liu, S.C.; Zhang, S.L.; Iwamori, M. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene. Biochimie 2010, 92, 852-857.
7. Kitajiri, S.; Hosaka, N.; Hiraumi, H.; Hirose, T.; Ikehara, S. Increased expression of integrin beta4 in papillary thyroid carcinoma with gross lymph node metastasis. Pathol. Int. 2002, 52, 438-441.
8. Kitamura, K.; Stockert, E.; Garin-Ghesa, P.; Welt, S.; Lloyd, K.O.; Armour, K.L.; Wallace, T.P.; Harris, W.J.; Carr, F.J.; Old, L.J. Specificity anaiysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc. Natl. Acad. Sci. USA 1994, 91, 12957-12961.
9. Yin, B.W.; Finstad, C.L.; Kitamura, K. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer 2006, 65, 406-412.
10. Baldus, S.E.; Hanisch, F.G.; Pütz, C. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol. Histopathol. 2002, 17, 191-198.
11. Hao, Y.Y.; Lin, B.; Zhang, Y.; Zhang, Y.H.; Li, F.F.; Diao, B.; Ouyang, L.; Zhang, S.L. Alpha 1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-1 cells. Fen Zi Xi Bao Sheng Wu Xue Bao 2008, 41, 435-442.
12. Maubant, S.; Cruet Hennequart, S.; Dutoit, S.; Denoux, Y.; Crouet, H.; Henry-Amar, M.; Gauduchon, P. Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens. J. Mol. Histol. 2005, 36, 119-129.
13. Haubner, R.; Wester, H.J. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr. Pharm. Des. 2004, 10, 1439-1455.
14. Hapke, S.; Kessler, H.; Luber, B.; Benge, A.; Hutzler, P.; Höfler, H.; Schmitt, M.; Reuning, U. Ovarian cancer cell proliferation and motility is induced by engagement of integrin avβ3/Vitronectin interaction. Biol. Chem. 2003, 384, 1073-1083.
15. Leroy-Dudal, J.; Demeilliers, C.; Gallet, O.; Pauthe, E.; Dutoit, S.; Agniel, R.; Gauduchon, P.; Carreiras, F. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves av integrins and the participation of MMP2. Int. J. Cancer 2005, 114, 531-543.
16. Carreiras, F.; Lehmann, M.; Sichel, F.; Marvaldi, J.; Gauduchon, P.; Le Talaer, J.Y. Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int. J. Cancer 1995, 63, 530-536.
17. Carreiras, F.; Thiebot, B.; Leroy-Dudal, J.; Maubant, S.; Breton, M.F.; Darbeida, H. Involvement of avβ3 integrin and disruption of endothelial fibronectin network during the adhesion of the human ovarian adenocarcinoma cell line IGROV1 on the human umbilical vein cell extracellular matrix. Int. J. Cancer 2002, 99, 800-808.
18. Davidson, B.; Goldberg, I.; Reich, R.; Tell, L.; Dong, H.P.; Trop, C.G.; Risberg, B.; Kopolovic, J. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol. Oncol. 2003, 90, 248-257.
19. Hapke, S.; Kessler, H.; Luber, B.; Benge, A.; Hutzler, P.; Hofler, H.; Schmitt, M.; Reuning, U. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v) beta3/Vitronectin interaction. Biol. Chem. 2003, 384, 1073-1083.
20. Cruet-Hennequart, S.; Maubant, S.; Luis, J.; Gauduchon, P.; Staedel, C.; Dedhar, S. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 2003, 22, 1688-1702.
21. Bsau, A.; Murthy, U.; Rodeck, U.; Herlyn, M.; Mattes, L.; Das, M. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res. 1987, 47, 2531-2536.
22. Klinger, M.; Farhan, H.; Just, H.; Drobny, H.; Himmler, G.; Loibner, H.; Mudde, G.C.; Freissuth, M.; Sexl, V. Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors. Cancer Res. 2004, 64, 1087-1093.
23. Lloyd, K.O.; Yin, B.W.; Kudryashov, V. Isolation and characterization of ovarian cancer antigen CAl25 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int. J. Cancer 1997, 71, 842-850.